Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Eiger BioPharmaceuticals, Inc. | General Counsel | Stock Option (Right to Buy) | 120K | Apr 30, 2023 | Direct | ||
BIODELIVERY SCIENCES INTERNATIONAL INC | General Counsel, Chief Compliance Officer & Corporate Secretary | Common Stock | 0 | $1.80 | Feb 4, 2022 | Direct | |
BIODELIVERY SCIENCES INTERNATIONAL INC | General Counsel, Chief Compliance Officer & Corporate Secretary | Restricted Stock Units | 0 | Mar 22, 2022 | Direct | ||
BIODELIVERY SCIENCES INTERNATIONAL INC | General Counsel, Chief Compliance Officer & Corporate Secretary | Stock Options (right to buy) | 0 | $3.66 | Mar 22, 2022 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
EIGR | Eiger BioPharmaceuticals, Inc. | Apr 30, 2023 | 1 | $0 | 4 | May 2, 2023 | General Counsel |
EIGR | Eiger BioPharmaceuticals, Inc. | Apr 12, 2023 | 0 | $0 | 3 | Apr 14, 2023 | General Counsel |
BDSI | BIODELIVERY SCIENCES INTERNATIONAL INC | Mar 22, 2022 | 6 | $0 | 4 | Mar 22, 2022 | General Counsel, Chief Compliance Officer & Corporate Secretary |
BDSI | BIODELIVERY SCIENCES INTERNATIONAL INC | Feb 4, 2022 | 2 | -$103K | 4 | Feb 8, 2022 | General Counsel, Chief Compliance Officer & Corporate Secretary |
BDSI | BIODELIVERY SCIENCES INTERNATIONAL INC | Jan 27, 2022 | 8 | $0 | 4 | Jan 31, 2022 | General Counsel, Chief Compliance Officer & Corporate Secretary |
BDSI | BIODELIVERY SCIENCES INTERNATIONAL INC | Jan 17, 2022 | 1 | $250K | 4 | Jan 19, 2022 | General Counsel, Chief Compliance Officer & Corporate Secretary |